Abstract

Structural neuroimaging data have been used to compute an estimate of the biological age of the brain (brain-age) which has been associated with other biologically and behaviorally meaningful measures of brain development and aging. The ongoing research interest in brain-age has highlighted the need for robust and publicly available brain-age models pre-trained on data from large samples of healthy individuals. To address this need we have previously released a developmental brain-age model. Here we expand this work to develop, empirically validate, and disseminate a pre-trained brain-age model to cover most of the human lifespan. To achieve this, we selected the best-performing model after systematically examining the impact of seven site harmonization strategies, age range, and sample size on brain-age prediction in a discovery sample of brain morphometric measures from 35,683 healthy individuals (age range: 5–90 years; 53.59% female). The pre-trained models were tested for cross-dataset generalizability in an independent sample comprising 2101 healthy individuals (age range: 8–80 years; 55.35% female) and for longitudinal consistency in a further sample comprising 377 healthy individuals (age range: 9–25 years; 49.87% female). This empirical examination yielded the following findings: (1) the accuracy of age prediction from morphometry data was higher when no site harmonization was applied; (2) dividing the discovery sample into two age-bins (5–40 and 40–90 years) provided a better balance between model accuracy and explained age variance than other alternatives; (3) model accuracy for brain-age prediction plateaued at a sample size exceeding 1600 participants. These findings have been incorporated into CentileBrain (https://centilebrain.org/#/brainAGE2), an open-science, web-based platform for individualized neuroimaging metrics.

Original languageEnglish
Article numbere26768
Number of pages14
JournalHuman Brain Mapping
Volume45
Issue number10
DOIs
Publication statusPublished - 15 Jul 2024

Bibliographical note

Publisher Copyright:
© 2024 The Author(s). Human Brain Mapping published by Wiley Periodicals LLC.

Funding

Avid Radiopharmaceuticals, Grant/Award Number: RF-2019-12370182; Bayer Oncology (Scientific Advisory Board); Eisai (ScientificAdvisory Board); Novo Nordisk (Scientific Advisory Board); Big Data to Knowledge (BD2K) Program, Grant/Award Number: U54EB020403; The ENIGMA World Aging Center, Grant/Award Number: R56 AG058854; The ENIGMA Sex Differences Initiative, Grant/Award Number: R01 MH116147; Marato TV3 Foundation, Grant/Award Number: 01/2010; Carlos III Health Institute, Grant/Award Number: PI040829; Knut and Alice Wallenberg (KAW) Foundation; Donders Centre for Cognitive Neuroimaging; Human Genetics and Cognitive Neuroscience departments of the Radboud university medical centre; Max Planck Institute for Psycholinguistics; Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL); Hersenstichting Nederland; Netherlands Organization for Scientific Research (NWO),i.e., the NWO Brain & Cognition Excellence Program, Grant/Award Number: 433-09-229; Vici Innovation Program, Grant/Award Numbers: 016-130-669, 91619115; European Community's Seventh Framework Programme (FP7/2007–2013), Grant/Award Numbers: 602805, 603016, 602450, 278948; NIH, Grant/Award Numbers: R01MH62873, P30AG010133, R01 AG019771, R01 CA129769, P30 AG072976, R01 AG057739, U01AG024904, R01 LM013463, R01 AG068193, T32 AG071444, U01 AG068057, U01AG072177, RC2DA029475; NWO Large Investment grant, Grant/Award Number: 1750102007010; ZonMW grant, Grant/Award Number: 60-60600-97-193; NWO, Grant/Award Numbers: 056-13-015,433-09-242; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; Vrije Universiteit Amsterdam; EU-AIMs programme; AIMS-2-TRIALS programme; Innovative Medicines Initiative Joint Undertaking grant, Grant/Award Numbers: 115300, 777394; European Federation of Pharmaceutical Industries and Associations (EFPIA); AUTISMSPEAKS; Autistica; SFARI; Horizon2020 supported programme CANDY grant, Grant/Award Number: 847818; European Community's Horizon 2020 Programme (H2020/2014–2020), Grant/Award Numbers: 643051, 667302, 847879; Netherlands Organization for Scientific Research (NWO) for the GUTS project, Grant/Award Number: 024.005.011; National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; German Research Foundation, Grant/Award Numbers: WA 1539/11-1, SFB-TRR58; National Institute of Mental Health (NIMH), Grant/Award Number: T32MH122394; Siemens Medical Solutions; American Epilepsy Society; Epilepsy Foundation; Epilepsy Therapy Project; Fight Against Childhood Epilepsy and Seizures (F.A.C.E.S.); Parents Against Childhood Epilepsy (P.A.C.E.); GE/NFL Head Health Challenge I; Indiana State Department of Health Spina lCord and Brain Injury Fund Research Grant Program; Project Development Team within the ICTSI NIH/NCRR, Grant/Award Number: RR025761; Italian ministry of health ricerca corrente 23; European Research Council, Grant/Award Number: ERC CoG PROSOCIAL 681632; Research Council of Norway, Grant/Award Numbers: 223273, 288083, 323951; South-Eastern Norway Regional Health Authority, Grant/Award Numbers: 2019069, 2021070, 2023012, 500189; National Health & Medical Research Council (NHMRC) Program, Grant/Award Numbers: ID350833, ID568969, APP1093083; Australian Research Council (ARC) Strategic Award Grant of the Ageing Well, Ageing Productively Program, Grant/Award Number: 401162; NHMRC Project (seed), Grant/Award Numbers: 1024224, 1025243; NHMRC Project, Grant/Award Numbers: 1045325, 1085606, 1064643, 1024570; NHMRC Program grants, Grant/Award Numbers: 568969, 1093083, R01AG059874,R01MH117601, R01NS107513, R01AG058854, P41EB015922; NHMRC Investigator Grant, Grant/Award Number: GNT2009771; Department of Energy, Grant/Award Number: DEFG02-99ER62764; Canadian Institutes of Health Research, Grant/Award Number: 126053; National Institute on Drug Abuse and the Eunice Kennedy Shriver National Institute of Child Health & Human Development; Health Research Board Ireland; NIMH, Grant/Award Number: 1R01MH085667-01A1; JohnS. Dunn Foundation (Houston, Texas); Pat Rutherford Chair in Psychiatry (UTHealth Houston); Dutch Research Council, Grant/Award Number: NWO 51.02.61; NWO-NIHC Programs of excellence, Grant/Award Number: 433-09-220

FundersFunder number
Avid RadiopharmaceuticalsRF-2019-12370182
Bayer Oncology
Eisai Limited
Novo Nordisk A/S
Big Data to Knowledge ProgramU54EB020403
ENIGMAR56 AG058854, R01 MH116147
Marato TV3 Foundation01/2010
Instituto de Salud Carlos IIIPI040829
Knut and Alice Wallenberg Foundation
Radboud University Medical Center
Max Planck Institute for Psycholinguistics
Biobanking and Biomolecular Resources Research Infrastructure
Hersenstichting
Nederlandse Organisatie voor Wetenschappelijk Onderzoek433-09-229, 016-130-669, 91619115, 1750102007010, 056-13-015, 433-09-242, 024.005.011, 433-09-220, 51.02.61
European Community's Seventh Framework Programme602805 , 603016, 602450, 278948
National Institutes of HealthR01MH62873, P30AG010133, R01 AG019771, R01 CA129769, P30 AG072976, R01 AG057739, U01AG024904, R01 LM013463, R01 AG068193, T32 AG071444, U01 AG068057, U01AG072177, RC2DA029475, RR025761
ZonMw60-60600-97-193
University Medical Center Groningen
Vrije Universiteit Amsterdam
EU-AIMs programme
AIMS-2-TRIALS programme
Innovative Medicines Initiatives1153001, 777394
European Federation of Pharmaceutical Industries and Associations
Autism Speaks Inc
Autistica
European Community's Horizon 2020 Programme847818, 643051, 667302, 847879
South London and Maudsley NHS Foundation Trust
Oxford National Institute for Health and Research (NIHR)
Kings College London, University of London
German Research FoundationWA 1539/11-1, SFB-TRR58
National Institute of Mental HealthT32MH122394, 1R01MH085667-01A1
Siemens Medical Solutions
American Epilepsy Society
Epilepsy Foundation
Epilepsy Therapy Project
Fight Against Childhood Epilepsy and Seizures
Parents Against Childhood Epilepsy
GE/NFL Head Health Challenge I
Indiana State Department of Health Spinal Cord and Brain Injury Fund Research Grant Program
Italian Ministry of Health Ricerca Corrente 23
European Research CouncilCoG PROSOCIAL681632
Research Council of Norway223273, 288083, 323951
South-Eastern Norway Regional Health Authority2019069, 2021070, 2023012, 500189
National Health and Medical Research CouncilID350833, ID568969, APP1093083, 1024224, 1025243, 1045325, 1085606, 1064643, 1024570, 568969, 1093083, R01AG059874, R01MH117601, R01NS107513, R01AG058854, P41EB015922, GNT2009771
Australian Research Council401162
United States Department of EnergyDEFG02-99ER62764
Canadian Institutes of Health Research126053
National Institute on Drug Abuse
Eunice Kennedy Shriver National Institute of Child Health & Human Development
Health Research Board Ireland
John S. Dunn Foundation
Pat Rutherford Chair in Psychiatry

    Keywords

    • Benchmarking
    • Brain aging
    • brainAGE

    Fingerprint

    Dive into the research topics of 'Brain-age prediction: Systematic evaluation of site effects, and sample age range and size'. Together they form a unique fingerprint.

    Cite this